SCHEMBL21339128

SCHEMBL21339128

CNC1Cc2ccccc2CN(SC)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ PDPK1 O15530 1/20 0.36
▸ MME P08473 2/20 0.36
▸ ACE P12821 2/20 0.36
▸ RAB9A P51151 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ IDO1 P14902 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14169913 0.80 ADRA2A (0.46) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14169906 0.79 RAB9A (0.45) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14169922 0.76 RAB9A (0.41) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14169908 0.76 ACE (0.43) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14169919 0.74 ALDH1A1 (0.39) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14169899 0.72 FNTA (0.50) KCNH2MMEACETSHRADORA2A
SCHEMBL21339127 0.70 ADRA2A (0.67) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL12894137 0.70 ANPEP (0.53) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14170136 0.67 ADRA2A (0.50) ADRA2AADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14193205 0.67 SLC6A2 (0.50) ADRA2AADRA2BADRA2CSLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019170919-A1 HYBRID MU OPIOID RECEPTOR AND NEUROPEPTIDE FF RECEPTOR BINDING MOLECULES, THEIR METHODS OF PREPARATION AND APPLICATIONS IN THERAPEUTIC TREATMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2019-09-12 — — WO disclosed
Send feedback